Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) — Market Cap & Net Worth
Market Cap & Net Worth: Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) has a market capitalization of $25.11 Million (Rs2.32 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #24395 globally and #1343 in its home market, demonstrating a 4.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aarey Drugs & Pharmaceuticals Limited's stock price Rs81.89 by its total outstanding shares 28354303 (28.35 Million). Review Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) financial obligations to assess the company's total debt and financial obligations.
Aarey Drugs & Pharmaceuticals Limited Market Cap History: 2021 to 2026
Aarey Drugs & Pharmaceuticals Limited's market capitalization history from 2021 to 2026. Data shows growth from $13.17 Million to $25.11 Million (13.96% CAGR).
Aarey Drugs & Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aarey Drugs & Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Aarey Drugs & Pharmaceuticals Limited's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.52x
Aarey Drugs & Pharmaceuticals Limited's market cap is 0.52 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $13.17 Million | $3.48 Billion | $65.14 Million | 0.00x | 0.20x |
| 2022 | $11.85 Million | $4.92 Billion | $65.55 Million | 0.00x | 0.18x |
| 2023 | $15.50 Million | $4.19 Billion | $37.71 Million | 0.00x | 0.41x |
| 2024 | $17.51 Million | $3.95 Billion | $46.84 Million | 0.00x | 0.37x |
| 2025 | $20.75 Million | $4.74 Billion | $40.24 Million | 0.00x | 0.52x |
Competitor Companies of AAREYDRUGS by Market Capitalization
Companies near Aarey Drugs & Pharmaceuticals Limited in the global market cap rankings as of June 19, 2026.
Key companies related to Aarey Drugs & Pharmaceuticals Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #555 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #601 globally with a market cap of $45.20 Billion USD ( CN¥308.87 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #555 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.94 |
| #601 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.20 Billion | CN¥48.42 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Aarey Drugs & Pharmaceuticals Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Aarey Drugs & Pharmaceuticals Limited's market cap moved from $13.17 Million to $ 25.11 Million, with a yearly change of 13.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs25.11 Million | +21.01% |
| 2025 | Rs20.75 Million | +18.51% |
| 2024 | Rs17.51 Million | +12.96% |
| 2023 | Rs15.50 Million | +30.79% |
| 2022 | Rs11.85 Million | -10.01% |
| 2021 | Rs13.17 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Aarey Drugs & Pharmaceuticals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.11 Million USD |
| MoneyControl | $25.11 Million USD |
| MarketWatch | $25.11 Million USD |
| marketcap.company | $25.11 Million USD |
| Reuters | $25.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl… Read more